Dasatinib and Therapeutic response delayed - a phase IV clinical study of FDA data

Summary:

Therapeutic response delayed is reported as a side effect among people who take Dasatinib (dasatinib), especially for people who are female, 60+ old, also take Iclusig, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Therapeutic response delayed when taking Dasatinib. It is created by eHealthMe based on reports of 9,399 people who have side effects when taking Dasatinib from the FDA, and is updated regularly.

What is Dasatinib?

Dasatinib has active ingredients of dasatinib. eHealthMe is studying from 9,407 Dasatinib users. Check the latest studies of Dasatinib.

What is Therapeutic response delayed?

Therapeutic response delayed (late preventive response) is found to be associated with 237 drugs and 366 conditions by eHealthMe. Check the latest studies of Therapeutic response delayed.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 03, 2026

9,399 people reported to have side effects when taking Dasatinib.
Among them, 20 people (0.21%) have Therapeutic response delayed.

Could Dasatinib cause Therapeutic response delayed?

Among these 20 people:

What is the gender of people who have Therapeutic response delayed when taking Dasatinib? *

female: 100 %
male: 0.0 %

What is the age of people who have Therapeutic response delayed when taking Dasatinib? *

What are other drugs people take besides Dasatinib? *

Iclusig: 2 people, 10.00%
Doxil: 1 person, 5.00%
Blincyto: 1 person, 5.00%

What are other side effects people have besides Therapeutic response delayed? *

Rashes (redness): 20 people, 100.00%
Fever: 20 people, 100.00%
Drug Resistance (reduction in effectiveness of a drug): 20 people, 100.00%
Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 20 people, 100.00%
Drug Ineffective: 16 people, 80.00%
Adverse Event: 4 people, 20.00%
Therapeutic Response Decreased (less preventive response): 3 people, 15.00%

What are the existing conditions these people have? *

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 20 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Dasatinib and have Therapeutic response delayed?

- Check whether Therapeutic response delayed is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dasatinib:

Dasatinib (9,407 reports)

Browse all side effects of Dasatinib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Therapeutic response delayed:

Therapeutic response delayed (237 drugs)

Browse all the conditions that are associated with Therapeutic response delayed:

Therapeutic response delayed (366 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dasatinib (the active ingredients of Dasatinib) and Dasatinib (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.